Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug

Monday, April 20, 2015 - 22:50 in Mathematics & Economics

A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net